Clinical correlation between different C-kit exon mutations and clinical outcome Imatinib mesylate treatment in Gist patients

Date

26 Feb 2019

Session

Cocktail and Poster viewing

Presenters

Ghada Zakaria

Citation

Annals of Oncology (2019) 30 (suppl_1): i12-i14. 10.1093/annonc/mdz026

Authors

G.Y. Zakaria1, N. Allahloubi2, A. Bahnasy3, O. Khorshid2

Author affiliations

  • 1 Oncology, Cairo Oncology Center Cairo University-CairoCure, 12311 - Cairo/EG
  • 2 Medical Oncology, NCI, Cairo/EG
  • 3 Cancer Biology, NCI, Cairo/EG
More

Resources

The clinical behavior of GISTs is highly variable. This study aims at detection of different histo-pathological tumor features and correlation with different clinical aspects after treatment with imatinib, based on C-KIT exon mutation status.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings